Health Insurance (General Medical Services Table) Amendment (Medication Reviews) Regulations 2017 (Cth)

Health Insurance (General Medical Services Table) Amendment (Medication Reviews) Regulations 2017

I, General the Honourable Sir Peter Cosgrove AK MC (Ret’d), Governor‑General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulations.

Dated 14 December 2017

Peter Cosgrove

Governor‑General

By His Excellency’s Command

Greg Hunt

Minister for Health

Contents

1Name

This instrument is the Health Insurance (General Medical Services Table) Amendment (Medication Reviews) Regulations 2017.

2Commencement

1. (1)

   Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1. The whole of this instrument	1 February 2018.	1 February 2018

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

1. (2)

   Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3Authority

This instrument is made under the Health Insurance Act 1973.

4Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

Health Insurance (General Medical Services Table) Regulations 2017

1. 1

   Schedule 1 (cell at item 900, column headed “Description”)

Repeal the cell, substitute:

Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a Domiciliary Medication Management Review (DMMR) for a patient living in a community setting, in which the medical practitioner, with the patient’s consent:

(a) assesses the patient as:

(i) having a chronic medical condition or a complex medication regimen; and

(ii) not having their therapeutic goals met; and

(b) following that assessment:

(i) refers the patient to a community pharmacy or an accredited pharmacist for the DMMR; and

(ii) provides relevant clinical information required for the DMMR; and

(c) discusses with the reviewing pharmacist the results of the DMMR including suggested medication management strategies; and

(d) develops a written medication management plan following discussion with the patient; and

(e) provides the written medication management plan to a community pharmacy chosen by the patient

For any particular patient—applicable not more than once in each 12 month period, except if there has been a significant change in the patient’s condition or medication regimen requiring a new DMMR